Ads
related to: novartis- About Us
We Help You Find the Right Software
With a Free, Expert Consultation
- Buyer's Guide
Explore Common Features And
Benefits of Medical Software
- About Us
Search results
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 hour agoAt BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with
US judge orders probe of Novartis $30 mln settlement claims process
Reuters· 8 hours agoA federal judge has ordered a probe of the claims distribution process in a $30 million settlement...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via Yahoo News· 17 hours agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into...
Why Novartis (NVS) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 11 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Novartis, Roche, Biogen and Samsung Bioepis in Italy Eye-Medicine Probe
Morningstar· 14 hours agoItaly's competition watchdog is investigating four pharmaceutical companies over what it called coordination of their commercial strategies, allegedly delaying access to a biosimilar eye-disease ...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment
Investing.com· 2 days agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
Ultra-Rich Families Fuel $20 Billion Private Equity Buyout Wave
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Ultra-rich individuals and families worth more than $150 billion are helping drive a...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 17 hours agoAnd hundreds of millions of dollars in investment have flown into new startups. Steffen Schuster,...
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive via Yahoo Finance· 7 days agoThe results are from a late-stage clinical trial run by Scemblix’s maker, Novartis, and will be...
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 6 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...